Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects
Public ClinicalTrials.gov record NCT04707768. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will be conducted to demonstrate the efficacy and safety of vadadustat administered three times weekly (TIW) compared to a long-acting erythropoiesis-stimulating agent (ESA) (Mircera®) for the maintenance treatment of anemia in hemodialysis participants.
Study identification
- NCT ID
- NCT04707768
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 456 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 18, 2021 (Actual)
- Primary completion
- Jan 6, 2023 (Actual)
- Completion
- Jan 30, 2023 (Actual)
- Last update posted
- Jan 15, 2025
2021 – 2023
United States locations
- U.S. sites
- 58
- U.S. states
- 23
- U.S. cities
- 54
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Huntsville | Alabama | 35805 | — |
| Research Site | Phoenix | Arizona | 85035 | — |
| Research Site | Pine Bluff | Arkansas | 71603 | — |
| Research Site | El Centro | California | 92243 | — |
| Research Site | Escondido | California | 92025 | — |
| Research Site | Fresno | California | 93720 | — |
| Research Site | Granada Hills | California | 91344 | — |
| Research Site | Porterville | California | 93257 | — |
| Research Site | San Diego | California | 92111 | — |
| Research Site | Arvada | Colorado | 80002 | — |
| Research Site | Denver | Colorado | 80210 | — |
| Research Site | Hockessin | Delaware | 19707 | — |
| Research Site | Bradenton | Florida | 34209 | — |
| Research Site | Coral Gables | Florida | 33134 | — |
| Research Site#1 | Coral Springs | Florida | 33071 | — |
| Research Site#2 | Coral Springs | Florida | 33071 | — |
| Research Site | Jacksonville | Florida | 32216 | — |
| Research Site | Athens | Georgia | 30606 | — |
| Research Site | Buford | Georgia | 30518 | — |
| Research Site | Dalton | Georgia | 30720 | — |
| Research Site | Macon | Georgia | 31201 | — |
| Research Site | Nampa | Idaho | 83687 | — |
| Research Site | Baton Rouge | Louisiana | 70884 | — |
| Research Site | Shreveport | Louisiana | 71101 | — |
| Research Site | Plymouth | Massachusetts | 02360 | — |
| Research Site | Springfield | Massachusetts | 01107 | — |
| Research Site | Kalamazoo | Michigan | 49007 | — |
| Research Site | Rochester Hills | Michigan | 48309 | — |
| Research Site | Saint Clair Shores | Michigan | 48081 | — |
| Research Site | Brookhaven | Mississippi | 39601 | — |
| Research Site | Columbus | Mississippi | 39705 | — |
| Research Site | Tupelo | Mississippi | 38801 | — |
| Research Site | North Platte | Nebraska | 69101 | — |
| Research Site | Las Vegas | Nevada | 89115 | — |
| Research Site | Reno | Nevada | 89511 | — |
| Research Site | Portsmouth | New Hampshire | 03801 | — |
| Research Site | Albuquerque | New Mexico | 87109 | — |
| Research Site | Gallup | New Mexico | 87301 | — |
| Research Site | Charlotte | North Carolina | 28204 | — |
| Research Site | Durham | North Carolina | 27704 | — |
| Research Site | Kinston | North Carolina | 28504 | — |
| Research Site | Raleigh | North Carolina | 27609 | — |
| Research Site | Columbus | Ohio | 43215 | — |
| Research Site | Kittanning | Pennsylvania | 16201 | — |
| Research Site | Knoxville | Tennessee | 37923 | — |
| Research Site | Arlington | Texas | 76015 | — |
| Research Site | Austin | Texas | 78758 | — |
| Research Site | Dallas | Texas | 75230 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | Houston | Texas | 77074 | — |
| Research Site | Houston | Texas | 77099 | — |
| Research Site | Mansfield | Texas | 76063 | — |
| Research Site | Mission | Texas | 78572 | — |
| Research Site | San Antonio | Texas | 78211 | — |
| Research Site | San Antonio | Texas | 78251 | — |
| Research Site | Alexandria | Virginia | 22304 | — |
| Research Site | Salem | Virginia | 24153 | — |
| Research Site | Woodbridge | Virginia | 22192 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04707768, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 15, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04707768 live on ClinicalTrials.gov.